Skip to main content
Top
Published in: Diabetologia 1/2012

01-01-2012 | Article

Exposure to the common food additive carrageenan leads to glucose intolerance, insulin resistance and inhibition of insulin signalling in HepG2 cells and C57BL/6J mice

Authors: S. Bhattacharyya, I. O-Sullivan, S. Katyal, T. Unterman, J. K. Tobacman

Published in: Diabetologia | Issue 1/2012

Login to get access

Abstract

Aims/hypothesis

The aim of this study was to determine the impact of the common food additive carrageenan (E407) on glucose tolerance, insulin sensitivity and insulin signalling in a mouse model and human hepatic cells, since carrageenan is known to cause inflammation through interaction with toll-like receptor (TLR)4, which is associated with inflammation in diabetes.

Methods

Male C57BL/6J mice were given carrageenan (10 mg/l) in their drinking water, and underwent a glucose tolerance test (GTT), an insulin tolerance test (ITT) and an ante-mortem intraperitoneal insulin injection. HepG2 cells were exposed to carrageenan (1 mg/l × 24 h) and insulin. Levels of phospho(Ser473)-protein kinase B (Akt), phospho(Ser307)-IRS1, phosphoinositide 3-kinase (PI3K) activity and phospho(Ser32)-inhibitor of κB (IκBα) were determined by western blotting and ELISA.

Results

Glucose tolerance was significantly impaired in carrageenan-treated 12-week-old mice compared with untreated controls at all time points (n = 12; p < 0.0001). Baseline insulin and insulin levels at 30 min after taking glucose during the GTT were significantly higher following carrageenan treatment. During the ITT, glucose levels declined by more than 80% in controls, but not in carrageenan-treated mice. Carrageenan exposure completely inhibited insulin-induced increases in phospho-(Ser473)-Akt and PI3K activity in vivo in mouse liver and in human HepG2 cells. Carrageenan increased phospho(Ser307)-IRS1 levels, and this was blocked when carrageenan-induced inflammation was inhibited.

Conclusion

This is the first report of the impact of carrageenan on glucose tolerance and indicates that carrageenan impairs glucose tolerance, increases insulin resistance and inhibits insulin signalling in vivo in mouse liver and human HepG2 cells. These effects may result from carrageenan-induced inflammation. The results demonstrate extra-colonic manifestations of ingested carrageenan and suggest that carrageenan in the human diet may contribute to the development of diabetes.
Literature
1.
go back to reference Tobacman JK (2001) Review of harmful gastrointestinal effects of carrageenan in animal experiments. Environ Health Perspect 109:983–994PubMedCrossRef Tobacman JK (2001) Review of harmful gastrointestinal effects of carrageenan in animal experiments. Environ Health Perspect 109:983–994PubMedCrossRef
2.
go back to reference Bhattacharyya S, Borthakur A, Dudeja PK, Tobacman JK (2007) Carrageenan induces interleukin-8 production through distinct Bcl10 pathway in normal human colonic epithelial cells. Am J Physiol Gastrointest Liver Physiol 292:G829–G838PubMed Bhattacharyya S, Borthakur A, Dudeja PK, Tobacman JK (2007) Carrageenan induces interleukin-8 production through distinct Bcl10 pathway in normal human colonic epithelial cells. Am J Physiol Gastrointest Liver Physiol 292:G829–G838PubMed
3.
go back to reference Bhattacharyya S, Gill R, Chen M-L, Zhang F, Linhardt RJ, Dudeja PK, Tobacman JK (2008) Toll-like receptor 4 mediates induction of Bcl10-NFκB-IL-8 inflammatory pathway by carrageenan in human intestinal epithelial cells. J Biol Chem 283:10550–10558PubMedCrossRef Bhattacharyya S, Gill R, Chen M-L, Zhang F, Linhardt RJ, Dudeja PK, Tobacman JK (2008) Toll-like receptor 4 mediates induction of Bcl10-NFκB-IL-8 inflammatory pathway by carrageenan in human intestinal epithelial cells. J Biol Chem 283:10550–10558PubMedCrossRef
4.
go back to reference Bhattacharyya S, Dudeja PK, Tobacman JK (2008) Carrageenan-induced NFκB activation depends on distinct pathways mediated by reactive oxygen species and Hsp27 or by Bcl10. Biochim Biophys Acta 1780:973–982PubMedCrossRef Bhattacharyya S, Dudeja PK, Tobacman JK (2008) Carrageenan-induced NFκB activation depends on distinct pathways mediated by reactive oxygen species and Hsp27 or by Bcl10. Biochim Biophys Acta 1780:973–982PubMedCrossRef
5.
go back to reference Bhattacharyya S, Borthakur A, Gill R, Chen ML, Dudeja PK, Tobacman JK (2010) BCL10 is required for NFκB nuclear translocation by both canonical and non-canonical pathways and for NIK phosphorylation. J Biol Chem 285:522–530PubMedCrossRef Bhattacharyya S, Borthakur A, Gill R, Chen ML, Dudeja PK, Tobacman JK (2010) BCL10 is required for NFκB nuclear translocation by both canonical and non-canonical pathways and for NIK phosphorylation. J Biol Chem 285:522–530PubMedCrossRef
6.
go back to reference Macher BA, Galili U (2008) The Gal-alpha-1,3-Gal-beta-1,4-GlcNAc-R (alpha-Gal) epitope: a carbohydrate of unique evolution and clinical relevance. Biochim Biophys Acta 1780:75–88PubMedCrossRef Macher BA, Galili U (2008) The Gal-alpha-1,3-Gal-beta-1,4-GlcNAc-R (alpha-Gal) epitope: a carbohydrate of unique evolution and clinical relevance. Biochim Biophys Acta 1780:75–88PubMedCrossRef
7.
go back to reference Tanemura M, Yin D, Chong AS, Galili U (2000) Differential immune responses to alpha-gal epitopes on xenografts and allografts: implications for accommodation in xenotransplantation. Clin Invest 105:301–310CrossRef Tanemura M, Yin D, Chong AS, Galili U (2000) Differential immune responses to alpha-gal epitopes on xenografts and allografts: implications for accommodation in xenotransplantation. Clin Invest 105:301–310CrossRef
8.
go back to reference Galili U (2005) The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy. Immunol Cell Biol 83:674–686PubMedCrossRef Galili U (2005) The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy. Immunol Cell Biol 83:674–686PubMedCrossRef
9.
go back to reference Bhattacharyya S, Liu H, Zhang Z et al (2010) Carrageenan-induced innate immune response is modified by enzymes that hydrolyze distinct galactosidic bonds. J Nutr Biochem 21:906–913PubMedCrossRef Bhattacharyya S, Liu H, Zhang Z et al (2010) Carrageenan-induced innate immune response is modified by enzymes that hydrolyze distinct galactosidic bonds. J Nutr Biochem 21:906–913PubMedCrossRef
10.
go back to reference Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS (2006) TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116:3015–3025PubMedCrossRef Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS (2006) TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116:3015–3025PubMedCrossRef
11.
go back to reference Song MJ, Kim KH, Yoon JM, Kim JB (2006) Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes. Biochem Biophys Res Commun 346:739–745PubMedCrossRef Song MJ, Kim KH, Yoon JM, Kim JB (2006) Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes. Biochem Biophys Res Commun 346:739–745PubMedCrossRef
12.
go back to reference Mohammad MK, Morran M, Slotterbeck B et al (2006) Dysregulated Toll-like receptor expression and signaling in bone marrow-derived macrophages at the onset of diabetes in the non-obese diabetic mouse. Int Immunol 18:1101–1113PubMedCrossRef Mohammad MK, Morran M, Slotterbeck B et al (2006) Dysregulated Toll-like receptor expression and signaling in bone marrow-derived macrophages at the onset of diabetes in the non-obese diabetic mouse. Int Immunol 18:1101–1113PubMedCrossRef
13.
go back to reference Committee on GRAS List Survey–Phase III. Food and Nutrition Board, National Research Council (1976) Estimating distribution of daily intakes of Chondrus extract (carrageenan). Appendix C. Washington, D.C.: National Academy of Sciences: 1–7 Committee on GRAS List Survey–Phase III. Food and Nutrition Board, National Research Council (1976) Estimating distribution of daily intakes of Chondrus extract (carrageenan). Appendix C. Washington, D.C.: National Academy of Sciences: 1–7
14.
go back to reference West J, Miller KN (2001) California’s living marine resources: a status report. Agarophytes and carrageenophytes. California Department of Fish and Game. pp. 286–287 West J, Miller KN (2001) California’s living marine resources: a status report. Agarophytes and carrageenophytes. California Department of Fish and Game. pp. 286–287
16.
go back to reference Shah ZC, Huffman FG (2003) Current availability and consumption of carrageenan-containing foods. Ecol Food Nutr 42:1–15CrossRef Shah ZC, Huffman FG (2003) Current availability and consumption of carrageenan-containing foods. Ecol Food Nutr 42:1–15CrossRef
18.
go back to reference Gao Z, Hwang D, Bataille F et al (2002) Serine phosphorylation of insulin receptor substrate 1 by inhibitor κB kinase complex. J Biol Chem 277:48115–48121PubMedCrossRef Gao Z, Hwang D, Bataille F et al (2002) Serine phosphorylation of insulin receptor substrate 1 by inhibitor κB kinase complex. J Biol Chem 277:48115–48121PubMedCrossRef
20.
go back to reference Tobacman JK, Wallace R, Zimmerman B (2001) Consumption of carrageenan and other water-soluble polymers used as food additives and incidence of mammary carcinoma in the United States in the twentieth century. Med Hypotheses 109:983–994 Tobacman JK, Wallace R, Zimmerman B (2001) Consumption of carrageenan and other water-soluble polymers used as food additives and incidence of mammary carcinoma in the United States in the twentieth century. Med Hypotheses 109:983–994
21.
go back to reference Food and Nutrition Board, National Research Council (1979) The 1977 Survey of Industry on the Use of Food Additives: Committee on GRAS List Survey—phase iii, part B. PB 80–113418. National Academy of Sciences, Washington DC Food and Nutrition Board, National Research Council (1979) The 1977 Survey of Industry on the Use of Food Additives: Committee on GRAS List Survey—phase iii, part B. PB 80–113418. National Academy of Sciences, Washington DC
22.
go back to reference Borthakur A, Bhattacharyya S, Alrefai W, Tobacman JK, Ramaswamy K, Dudeja PK (2010) Platelet activating factor-induced NF-κB activation and IL-8 production in intestinal epithelial cells are Bcl10 dependent. Inflamm Bowel Dis 16:593–603PubMed Borthakur A, Bhattacharyya S, Alrefai W, Tobacman JK, Ramaswamy K, Dudeja PK (2010) Platelet activating factor-induced NF-κB activation and IL-8 production in intestinal epithelial cells are Bcl10 dependent. Inflamm Bowel Dis 16:593–603PubMed
23.
go back to reference Willis TG, Jadayel DM, Du MQ et al (1999) Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 96:35–45PubMedCrossRef Willis TG, Jadayel DM, Du MQ et al (1999) Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 96:35–45PubMedCrossRef
24.
go back to reference Zhang Q, Siebert R, Yan M et al (1999) Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32). Nat Genet 22:63–68PubMedCrossRef Zhang Q, Siebert R, Yan M et al (1999) Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32). Nat Genet 22:63–68PubMedCrossRef
25.
go back to reference Marcus SN, Marcus AJ, Marcus R, Ewen SW, Watt J (1992) The pre-ulcerative phase of carrageenan-induced colonic ulcerations in the guinea pig. Int J Exp Pathol 73:515–526PubMed Marcus SN, Marcus AJ, Marcus R, Ewen SW, Watt J (1992) The pre-ulcerative phase of carrageenan-induced colonic ulcerations in the guinea pig. Int J Exp Pathol 73:515–526PubMed
26.
go back to reference Nicklin S, Miller K (1980) Effects of orally administered food-grade carrageenan on antibody-mediated and cell-mediated immunity in the inbred rat. Food Chem Toxicol 22:615–621 Nicklin S, Miller K (1980) Effects of orally administered food-grade carrageenan on antibody-mediated and cell-mediated immunity in the inbred rat. Food Chem Toxicol 22:615–621
27.
go back to reference Thomson AW, Fowler EF (1981) Carrageenan: a review of its effects on the immune system. Agents Actions 11:265–273PubMedCrossRef Thomson AW, Fowler EF (1981) Carrageenan: a review of its effects on the immune system. Agents Actions 11:265–273PubMedCrossRef
28.
go back to reference Hacker H, Karin M (2006) Regulation and function of IKK and IKK-related kinases. Sci STKE; (357): re13 Hacker H, Karin M (2006) Regulation and function of IKK and IKK-related kinases. Sci STKE; (357): re13
29.
go back to reference Bhattacharyya S, Borthakur A, Dudeja PK, Tobacman JK (2008) Carrageenan induces cell cycle arrest in human intestinal epithelial cells in vitro. J Nutr 138:469–475PubMed Bhattacharyya S, Borthakur A, Dudeja PK, Tobacman JK (2008) Carrageenan induces cell cycle arrest in human intestinal epithelial cells in vitro. J Nutr 138:469–475PubMed
30.
go back to reference Hsu PP, Kang SA, Rameseder J et al (2011) The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 332:1317–1322PubMedCrossRef Hsu PP, Kang SA, Rameseder J et al (2011) The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 332:1317–1322PubMedCrossRef
31.
go back to reference Yu Y, Yoon S-O, Poulogiannis G et al (2011) Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling. Science 332:1322–1326PubMedCrossRef Yu Y, Yoon S-O, Poulogiannis G et al (2011) Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling. Science 332:1322–1326PubMedCrossRef
Metadata
Title
Exposure to the common food additive carrageenan leads to glucose intolerance, insulin resistance and inhibition of insulin signalling in HepG2 cells and C57BL/6J mice
Authors
S. Bhattacharyya
I. O-Sullivan
S. Katyal
T. Unterman
J. K. Tobacman
Publication date
01-01-2012
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 1/2012
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-011-2333-z

Other articles of this Issue 1/2012

Diabetologia 1/2012 Go to the issue